Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mancheng Gong

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Indian Journal of Cancer|December 2, 2024
Relationship between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in peripheral blood and prognosis after castration therapy for prostate cancerHao Wu, Mancheng Gong, Runqiang Yuan
DNA and Cell Biology|February 21, 2012
Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studiesMancheng Gong, Wenjing Dong, Ruihua An
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 19, 2013
USP28 is a potential prognostic marker for bladder cancerGuiying Guo, Yangyang Xu, Mancheng Gong, et al.
Oncotarget|January 1, 2017
Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studiesMancheng Gong, Wenjing Dong, Zhirong Shi, et al.
Frontiers in Genetics|February 22, 2021
Enhanced Expression of <i>CNTD2/CCNP</i> Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507Mancheng Gong, Erlin Song, Guiying Huang, et al.
Plos One|November 29, 2012
Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studiesMancheng Gong, Wenjing Dong, Zhirong Shi, et al.
Annals of Translational Medicine|June 20, 2022
Long non-coding RNA (FALEC) promotes malignant behaviors of gastric cancer cells by regulating miR-203b/PIM3 axisWenjing Dong, Mancheng Gong, Jianjun Xiao, et al.
Cancer Biology & Therapy|August 7, 2013
Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatmentYangyang Xu, Xin Gu, Mancheng Gong, et al.
Plos One|April 1, 2016
Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control StudiesWenjing Dong, Mancheng Gong, Zhirong Shi, et al.
Oncotargets and Therapy|August 10, 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinomaWenjun Ni, Erlin Song, Mancheng Gong, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Indian Journal of Cancer|December 2, 2024
Relationship between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in peripheral blood and prognosis after castration therapy for prostate cancerHao Wu, Mancheng Gong, Runqiang Yuan
DNA and Cell Biology|February 21, 2012
Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studiesMancheng Gong, Wenjing Dong, Ruihua An
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 19, 2013
USP28 is a potential prognostic marker for bladder cancerGuiying Guo, Yangyang Xu, Mancheng Gong, et al.
Oncotarget|January 1, 2017
Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studiesMancheng Gong, Wenjing Dong, Zhirong Shi, et al.
Frontiers in Genetics|February 22, 2021
Enhanced Expression of <i>CNTD2/CCNP</i> Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507Mancheng Gong, Erlin Song, Guiying Huang, et al.
Plos One|November 29, 2012
Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studiesMancheng Gong, Wenjing Dong, Zhirong Shi, et al.
Annals of Translational Medicine|June 20, 2022
Long non-coding RNA (FALEC) promotes malignant behaviors of gastric cancer cells by regulating miR-203b/PIM3 axisWenjing Dong, Mancheng Gong, Jianjun Xiao, et al.
Cancer Biology & Therapy|August 7, 2013
Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatmentYangyang Xu, Xin Gu, Mancheng Gong, et al.
Plos One|April 1, 2016
Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control StudiesWenjing Dong, Mancheng Gong, Zhirong Shi, et al.
Oncotargets and Therapy|August 10, 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinomaWenjun Ni, Erlin Song, Mancheng Gong, et al.
Pageof 3